RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,130 | -56.7% | 1,710 | -64.5% | 0.00% | – |
| Q2 2023 | $11,850 | +118400.0% | 4,817 | +4.3% | 0.00% | – |
| Q1 2023 | $10 | -88.1% | 4,619 | -80.8% | 0.00% | -100.0% |
| Q4 2022 | $84 | -99.7% | 24,041 | +2721.7% | 0.00% | +200.0% |
| Q3 2022 | $32,000 | +14.3% | 852 | -42.0% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | +366.7% | 1,469 | +606.2% | 0.00% | – |
| Q1 2022 | $6,000 | -78.6% | 208 | -83.0% | 0.00% | – |
| Q4 2021 | $28,000 | +55.6% | 1,227 | +80.2% | 0.00% | – |
| Q3 2021 | $18,000 | -45.5% | 681 | -34.6% | 0.00% | -100.0% |
| Q2 2021 | $33,000 | -47.6% | 1,041 | -42.1% | 0.00% | 0.0% |
| Q1 2021 | $63,000 | +70.3% | 1,798 | +52.6% | 0.00% | 0.0% |
| Q4 2020 | $37,000 | -92.0% | 1,178 | -90.4% | 0.00% | -80.0% |
| Q3 2020 | $462,000 | +1055.0% | 12,282 | +1263.2% | 0.01% | +150.0% |
| Q2 2020 | $40,000 | -52.4% | 901 | -58.0% | 0.00% | -71.4% |
| Q4 2019 | $84,000 | – | 2,143 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |